E-LIB Suche - Ergebnisse für: Dal-Ré, Rafael

1

Is "interventional trial" a correct term to use in clinical..:

Dal-Ré, Rafael
European Journal of Clinical Pharmacology. 80 (2024) 7 - p. 1107-1109 , 2024

Link: https://doi.org/10.1007/..

2

Challenges in conducting efficacy trials for new COVID-19 v..:

Dal-Ré, Rafael ; Bottieau, Emmanuel ; Launay, Odile..
Clinical Trials. , 2024

Link: https://doi.org/10.1177/..

3

Revisión por pares: consideraciones a las propuestas de Can..:

Dal-Ré, Rafael
Anales de Pediatría. 100 (2024) 4 - p. 311-312 , 2024

Link: https://doi.org/10.1016/..

4

Adequate information about clinical trial results must be g..:

Dal-Ré, Rafael ; Caplan, Arthur L. ; Holm, Søren..
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

5

Peer-review: Considerations to Candal-Pedreira et al.'s pro..:

Dal-Ré, Rafael
Anales de Pediatría (English Edition). 100 (2024) 4 - p. 311-312 , 2024

Link: https://doi.org/10.1016/..

6

The definition of research misconduct should be stated in t..:

Dal-Ré, Rafael ; Marušić, Ana
Accountability in Research. , 2024

Link: https://doi.org/10.1080/..

7

Voluntary transparency of sponsors of medicines clinical tr..:

Dal-Ré, Rafael
Journal of Clinical Epidemiology. 169 (2024) - p. 111282 , 2024

Link: https://doi.org/10.1016/..

8

Is full transparency in clinical trials an achievable goal?:

Dal-Ré, Rafael
European Journal of Internal Medicine. 123 (2024) - p. 1-3 , 2024

Link: https://doi.org/10.1016/..

9

'Pragmatic' or 'streamlined': Which term best fits the REMA..:

Dal-Ré, Rafael
European Journal of Internal Medicine. 113 (2023) - p. 119-121 , 2023

Link: https://doi.org/10.1016/..

10

COVID-19 research waste: An analysis on terminated clinical..:

Dal-Ré, Rafael
European Journal of Internal Medicine. 117 (2023) - p. 126-128 , 2023

Link: https://doi.org/10.1016/..

11

Waivers of informed consent in research with competent part..:

Dal-Ré, Rafael
European Journal of Clinical Pharmacology. 79 (2023) 4 - p. 575-578 , 2023

Link: https://doi.org/10.1007/..

12

'Time out'—more transparency is required in 'Just-in-time' ..:

Dal-Ré, Rafael ; Caplan, Arthur L ; Voo, Teck Chuan
European Journal of Internal Medicine. 108 (2023) - p. 100-101 , 2023

Link: https://doi.org/10.1016/..

13

Informed consent process in the I-SPY COVID trial is questi..:

Dal-Ré, Rafael ; Caplan, Arthur L ; Voo, Teck Chuan
European Journal of Internal Medicine. 107 (2023) - p. 98-99 , 2023

Link: https://doi.org/10.1016/..

14

Using the phases of clinical development of medicines to de..:

Dal-Ré, Rafael ; Banzi, Rita ; Cristea, Ioana A....
Journal of Clinical Epidemiology. 161 (2023) - p. 157-163 , 2023

Link: https://doi.org/10.1016/..

15

Leading pharmaceutical companies lacked transparency on cli..:

Dal-Ré, Rafael ; Voo, Teck Chuan ; Holm, Søren
Journal of Clinical Epidemiology. 162 (2023) - p. 187-189 , 2023

Link: https://doi.org/10.1016/..